DRKS00025832Recruiting未知
SimSaarlabim
KS Saarland, Klinik für Allgemeine Pädiatrie und Neonatologie0 sites81 target enrollmentStarted: July 20, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 81
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 6 Years to 10 Years (—)
- Sex
- All
Inclusion Criteria
- •Children aged 6-10 years, who will receive a vaccination (STIKO recommended vaccination or Influenca vaccination)
- •Parental consent
Exclusion Criteria
- •Children < 6 years of age or > 10 years of age
- •Lack of parental consent
- •Intake of analgesic medication < 8 h prior to vaccination (eg, Paracetamol, ibuprofen)
Investigators
Similar Trials
Active, not recruiting
Phase 1
/AMedDRA version: 18.0 Level: PT Classification code 10007515 Term: Cardiac arrest System Organ Class: 10007541 - Cardiac disordersEUCTR2014-002010-24-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)462
Active, not recruiting
Phase 1
AAEUCTR2020-004359-34-FRAssistance Publique – Hôpitaux de Paris (AP-HP)10
Active, not recruiting
Not Applicable
Untitled Study-MedDRA version: 16.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-004463-41-PTMedica Scientia Innovation Research (MedSIR ARO)60
Active, not recruiting
Not Applicable
Untitled Study-MedDRA version: 15.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-004463-41-ESMedica Scientia Innovation Research (MedSIR ARO)60
Active, not recruiting
Phase 1
Eurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase I/II explorative, open label, controlled, randomized studyCTIS2023-508977-10-00Mimetech S.r.l.24